Tag: Recro Pharma

FB Nasdaq FB Facebook
Finance

Biotech New Highs: Sinovac Biotech (NASDAQ:SVA), Neuralstem (NYSEMKT:CUR), Durata Therapeutics Inc (NASDAQ:DRTX), Recro Pharma (NASDAQ:REPH)

Sinovac Biotech Ltd (NASDAQ:SVA) a leading biopharmaceutical company in China has reported its fourth quarter and full year unaudited results for the period ending December 31, 2013. Sinovac Biotech Ltd. (NASDAQ:SVA) stock performance was 17.13% in last session and finished the day at $8.07. Traded volume was 4,876,818 million shares in the last session and the average volume of the stock remained 342.45 million shares. … Continue reading Biotech New Highs: Sinovac Biotech (NASDAQ:SVA), Neuralstem (NYSEMKT:CUR), Durata Therapeutics Inc (NASDAQ:DRTX), Recro Pharma (NASDAQ:REPH)

Chris Lewis
Finance

Stocks in Focus : Facebook Inc (NASDAQ:FB), Micron Technology, Inc. (NASDAQ:MU), Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Recro Pharma, Inc. (NASDAQ:REPH), Excel Trust (NYSE:EXL)

Facebook Inc. (NASDAQ:FB), which closed its acquisition of mobile messaging service WhatsApp on Monday, has no near-term plan to make money from the service, Chief Executive Mark Zuckerberg said on Thursday. Facebook Inc (NASDAQ:FB) belongs to Technology sector. Its net profit margin is 23.70% and weekly performance is -5.85%. On last trading day company shares ended up $72.91. Facebook Inc (NASDAQ:FB) distance from 50-day simple … Continue reading Stocks in Focus : Facebook Inc (NASDAQ:FB), Micron Technology, Inc. (NASDAQ:MU), Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Recro Pharma, Inc. (NASDAQ:REPH), Excel Trust (NYSE:EXL)

Jayne Crisman